{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:51Z","timestamp":1792785891698,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea Health Technology R&D"},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2023-00265440"],"award-info":[{"award-number":["RS-2023-00265440"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Sarcopenia, characterized by reduced muscle mass and function, has been increasingly implicated in cardiovascular disorders. However, its prognostic relevance in atrial fibrillation (AF) remains unclear. We aimed to evaluate the association between sarcopenia and adverse outcomes in individuals with AF using UK Biobank data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This retrospective cohort study included individuals with AF enrolled between 2006 and 2010 at 22 centres. Sarcopenia was defined per European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria as low muscle strength and\/or low muscle mass measured by handgrip and bioelectrical impedance analysis. Propensity score weighting adjusted for baseline differences. The primary outcome was a composite of all-cause mortality, major bleeding, thromboembolic events (stroke\/systemic embolism), and heart failure admission; each component was also assessed individually. Among 5144 patients with AF (median age, 64.0 years; 24.1% female), 16.7% had sarcopenia. After propensity score weighting, sarcopenia was associated with a higher incidence of the primary composite outcome [43.9 per 1000 person-years (PYRs)], with an adjusted hazard ratio (HR) of 1.30 [95% confidence interval (CI), 1.15\u20131.46]. This risk was mainly driven by elevated rates of all-cause mortality (26.4 per 1000 PYRs; aHR, 1.44; 95% CI 1.24\u20131.68) and major bleeding (14.4 per 1000 PYRs; aHR, 1.34; 95% CI 1.10\u20131.65). Subgroup analyses demonstrated consistent results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Even after PS weighting analysis, some residual confounders may remain; however, sarcopenia was independently associated with adverse clinical outcomes, particularly mortality and bleeding risk. Screening for sarcopenia may enhance risk stratification and management, particularly in patients receiving anticoagulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euaf286","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:12:31Z","timestamp":1762434751000},"source":"Crossref","is-referenced-by-count":5,"title":["Sarcopenia in atrial fibrillation: a risk factor for adverse outcomes in a UK Biobank study"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3510-3774","authenticated-orcid":false,"given":"Hong-Ju","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine , 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722 ,","place":["Republic of Korea"]},{"name":"Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine , Daegu ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6552-1742","authenticated-orcid":false,"given":"Pil-Sung","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine , 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjin","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine , 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9736-450X","authenticated-orcid":false,"given":"Daehoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine , 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7212-9979","authenticated-orcid":false,"given":"Han-Joon","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Daegu Catholic University School of Medicine , Daegu ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9338-0679","authenticated-orcid":false,"given":"Chan-Hee","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine , Daegu ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8109-5018","authenticated-orcid":false,"given":"Jang-won","family":"Son","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine , Daegu ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6009-1843","authenticated-orcid":false,"given":"Ung","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine , Daegu ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-7225","authenticated-orcid":false,"given":"Boyoung","family":"Joung","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine , 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"key":"2025122222563289200_euaf286-B1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ahj.2018.04.017","article-title":"10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population","volume":"202","author":"Kim","year":"2018","journal-title":"Am Heart J"},{"key":"2025122222563289200_euaf286-B2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"2025122222563289200_euaf286-B3","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2025122222563289200_euaf286-B4","doi-asserted-by":"crossref","first-page":"euae298","DOI":"10.1093\/europace\/euae298","article-title":"Spotlight on the 2024 ESC\/EACTS management of atrial fibrillation guidelines: 10 novel key aspects","volume":"26","author":"Rienstra","year":"2024","journal-title":"Europace"},{"key":"2025122222563289200_euaf286-B5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2025122222563289200_euaf286-B6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4070\/kcj.2018.0339","article-title":"2018 Korean guideline of atrial fibrillation management","volume":"48","author":"Joung","year":"2018","journal-title":"Korean Circ J"},{"key":"2025122222563289200_euaf286-B7","doi-asserted-by":"crossref","first-page":"990s","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: origins and clinical relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J Nutr"},{"key":"2025122222563289200_euaf286-B8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/europace\/euac123","article-title":"EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)","volume":"25","author":"Savelieva","year":"2023","journal-title":"Europace"},{"key":"2025122222563289200_euaf286-B9","doi-asserted-by":"crossref","first-page":"102111","DOI":"10.1016\/j.arr.2023.102111","article-title":"Frailty and sarcopenia: a bibliometric analysis of their association and potential targets for intervention","volume":"92","author":"Ye","year":"2023","journal-title":"Ageing Res Rev"},{"key":"2025122222563289200_euaf286-B10","doi-asserted-by":"crossref","first-page":"155557","DOI":"10.1016\/j.metabol.2023.155557","article-title":"Sarcopenia in youth","volume":"144","author":"Jung","year":"2023","journal-title":"Metabolism"},{"key":"2025122222563289200_euaf286-B11","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/jcsm.13337","article-title":"Effects of sarcopenia and frailty on postoperative recovery in elderly patients: a prospective cohort study","volume":"14","author":"Guo","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025122222563289200_euaf286-B12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7861\/clinmedicine.16-5-455","article-title":"Sarcopenia and frailty: new challenges for clinical practice","volume":"16","author":"Dodds","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"2025122222563289200_euaf286-B13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"2025122222563289200_euaf286-B14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/jcsm.13221","article-title":"Sarcopenia and cardiovascular diseases: a systematic review and meta-analysis","volume":"14","author":"Zuo","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025122222563289200_euaf286-B15","doi-asserted-by":"crossref","first-page":"101264","DOI":"10.1016\/j.eclinm.2021.101264","article-title":"Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China Health and Retirement Longitudinal Study","volume":"44","author":"Gao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2025122222563289200_euaf286-B16","doi-asserted-by":"crossref","first-page":"e14198","DOI":"10.1111\/acel.14198","article-title":"Association of sarcopenia with the long-term risk of atrial fibrillation: a prospective cohort study","volume":"23","author":"Tang","year":"2024","journal-title":"Aging Cell"},{"key":"2025122222563289200_euaf286-B17","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"2025122222563289200_euaf286-B18","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2025122222563289200_euaf286-B19","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/jce.15202","article-title":"Risk of sick sinus syndrome in patients diagnosed with atrial fibrillation: a population-based cohort","volume":"32","author":"Yang","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025122222563289200_euaf286-B20","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"key":"2025122222563289200_euaf286-B21","volume-title":"Health and Deprivation: Inequality and the North","author":"Townsend","year":"1988"},{"key":"2025122222563289200_euaf286-B22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"2025122222563289200_euaf286-B23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2025122222563289200_euaf286-B24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.31083\/j.rcm2505164","article-title":"Clinical implications of polypharmacy for patients with new-onset atrial fibrillation based on real-world data: observations from the Korea National Health Insurance Service data","volume":"25","author":"Kim","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"2025122222563289200_euaf286-B25","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1038\/s41598-023-32229-9","article-title":"Association of obesity with incident atrial fibrillation in Korea and the United Kingdom","volume":"13","author":"Choi","year":"2023","journal-title":"Sci Rep"},{"key":"2025122222563289200_euaf286-B26","doi-asserted-by":"crossref","first-page":"e019482","DOI":"10.1161\/JAHA.120.019482","article-title":"Changes in cardiovascular risk factors and cardiovascular events in the elderly population","volume":"10","author":"Yang","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2025122222563289200_euaf286-B27","doi-asserted-by":"crossref","first-page":"n991","DOI":"10.1136\/bmj.n991","article-title":"Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study","volume":"373","author":"Kim","year":"2021","journal-title":"BMJ"},{"key":"2025122222563289200_euaf286-B28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3892\/ijmm.2021.4989","article-title":"Pathophysiology and mechanisms of primary sarcopenia (review)","volume":"48","author":"Nishikawa","year":"2021","journal-title":"Int J Mol Med"},{"key":"2025122222563289200_euaf286-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2017.01.006","article-title":"Frailty and sarcopenia: the potential role of an aged immune system","volume":"36","author":"Wilson","year":"2017","journal-title":"Ageing Res Rev"},{"key":"2025122222563289200_euaf286-B30","first-page":"1480","article-title":"Low skeletal muscle mass is associated with the presence, incidence, and progression of coronary artery calcification","volume":"37","author":"Jun","year":"2021","journal-title":"Can J Cardiol"},{"key":"2025122222563289200_euaf286-B31","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/ejhf.1304","article-title":"Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"20","author":"Emami","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2025122222563289200_euaf286-B32","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/ATVBAHA.116.307156","article-title":"Relationship between low relative muscle mass and coronary artery calcification in healthy adults","volume":"36","author":"Ko","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025122222563289200_euaf286-B33","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/gerona\/glab098","article-title":"Sarcopenia and neuroscience: learning to communicate","volume":"76","author":"Clark","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2025122222563289200_euaf286-B34","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.7150\/thno.33000","article-title":"New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure","volume":"9","author":"Yin","year":"2019","journal-title":"Theranostics"},{"key":"2025122222563289200_euaf286-B35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2025122222563289200_euaf286-B36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jcsm.13401","article-title":"Cross-sectional and longitudinal association between atrial fibrillation and sarcopenia: findings from the Korean frailty and aging cohort study","volume":"15","author":"Shim","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025122222563289200_euaf286-B37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"2025122222563289200_euaf286-B38","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"key":"2025122222563289200_euaf286-B39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/europace\/euac022","article-title":"Impact of oral anticoagulation on the association between frailty and clinical outcomes in people with atrial fibrillation: nationwide primary care records on treatment analysis","volume":"24","author":"Wilkinson","year":"2022","journal-title":"Europace"},{"key":"2025122222563289200_euaf286-B40","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/STROKEAHA.121.036757","article-title":"Effectiveness and safety of anticoagulation therapy in frail patients with atrial fibrillation","volume":"53","author":"Kim","year":"2022","journal-title":"Stroke"},{"key":"2025122222563289200_euaf286-B41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/europace\/euaa242","article-title":"Non-vitamin K oral anticoagulants and risk of fractures: a systematic review and meta-analysis","volume":"23","author":"Mongkhon","year":"2021","journal-title":"Europace"},{"key":"2025122222563289200_euaf286-B42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12916-020-01870-w","article-title":"Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial","volume":"18","author":"Wilkinson","year":"2020","journal-title":"BMC Med"},{"key":"2025122222563289200_euaf286-B43","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-dose edoxaban in very elderly patients with atrial fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N Engl J Med"},{"key":"2025122222563289200_euaf286-B44","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"2025122222563289200_euaf286-B45","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2025122222563289200_euaf286-B46","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1136\/heartjnl-2017-312930","article-title":"Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015","volume":"104","author":"Kim","year":"2018","journal-title":"Heart"},{"key":"2025122222563289200_euaf286-B47","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jacc.2018.05.076","article-title":"Ideal blood pressure in patients with atrial fibrillation","volume":"72","author":"Kim","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025122222563289200_euaf286-B48","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/eurheartj\/ehy877","article-title":"Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population","volume":"40","author":"Kim","year":"2019","journal-title":"Eur Heart J"},{"key":"2025122222563289200_euaf286-B49","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz386","article-title":"Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort","volume":"40","author":"Kim","year":"2019","journal-title":"Eur Heart J"},{"key":"2025122222563289200_euaf286-B50","doi-asserted-by":"publisher","first-page":"euad226","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip","year":"2023","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euaf286\/65244156\/euaf286.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/12\/euaf286\/65244156\/euaf286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/12\/euaf286\/65244156\/euaf286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T03:56:46Z","timestamp":1766462206000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euaf286\/8316997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaf286","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,8]]},"article-number":"euaf286"}}